Phio Pharmaceuticals (FRA:44R3) Beginning Cash Position : €7.81 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Phio Pharmaceuticals Beginning Cash Position?

Phio Pharmaceuticals's Beginning Cash Position for the quarter that ended in Mar. 2024 was €7.81 Mil.

Phio Pharmaceuticals's quarterly Beginning Cash Position declined from Sep. 2023 (€10.64 Mil) to Dec. 2023 (€7.75 Mil) but then increased from Dec. 2023 (€7.75 Mil) to Mar. 2024 (€7.81 Mil).

Phio Pharmaceuticals's annual Beginning Cash Position increased from Dec. 2021 (€12.65 Mil) to Dec. 2022 (€22.76 Mil) but then declined from Dec. 2022 (€22.76 Mil) to Dec. 2023 (€10.85 Mil).

Phio Pharmaceuticals Beginning Cash Position Historical Data

The historical data trend for Phio Pharmaceuticals's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Phio Pharmaceuticals Beginning Cash Position Chart

Phio Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

13.44

5.74

12.65

22.76

10.85

Phio Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial															11.05	8.39	10.64	7.75	7.81

Phio Pharmaceuticals Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Phio Pharmaceuticals Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Phio Pharmaceuticals's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Phio Pharmaceuticals (FRA:44R3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Phio Pharmaceuticals Corp (FRA:44R3) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

PHIO:USA

Address

257 Simarano Drive, Suite 101, Marlborough, MA, USA, 01752

Website

https://www.phiopharma.com

Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipeline products include PH-762, PH-804, PH-790, and others.

Phio Pharmaceuticals (FRA:44R3) Headlines

No Headlines